Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
LIMES Schlosskliniken AG operates private clinics specializing in the treatment of stress-related illnesses, mental, and emotional disorders, including depression, affective disorders, and acute burnout conditions. The company offers services primarily to private patients, those entitled to subsidies, and self-payers. Headquartered in Cologne, Germany, LIMES Schlosskliniken has expanded its geographic footprint through acquisitions, such as a 51% stake in Liechtenstein's Clinicum Alpinum AG in 2023, and increasing its stake in Switzerland's PRC Group AG to 56% in the same year. (,) In June 2025, the company opened LIMES Schlossklinik Abtsee, a specialized clinic for young adults aged 14 to 21, located near Salzburg, Austria. This strategic expansion enhances the company's service offerings and international presence.
View stock
VS
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
View stock

Stock highlights

Stock comparison highlights
Stock name
LIMES Schlosskliniken AGJohnson & Johnson
Last price
€525.00$263.81
Currency
EUR
USD
€156M$621B
28.6439.15
€18.33$6.58
0.880.21
€10.00$5.28
1.90%2.08%
Sector
HealthHealth
Employees
314138,200
Ticker
€LIK$JNJ
Primary listing
XETRANYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €LIK or $JNJ on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.